Magellan Global Opportunities Fund highlighted UnitedHealth Group as a top contributor in the second quarter of 2026, citing a recovery driven by strong first-quarter results. The medical care ratio improved to 83.9% from 84.8% a year earlier, prompting management to raise full-year 2026 adjusted earnings per share guidance. The fund noted that UnitedHealth prioritized margin recovery over membership growth, including trimming Medicare Advantage membership and restoring operational discipline at Optum Health. Softer industry-wide medical cost trends and a larger-than-proposed 2027 Medicare Advantage rate increase further supported sentiment. UnitedHealth shares closed at $418.52 on July 15, 2026, with a one-month return of 4.38% and a 52-week gain of 45.28%, giving the company a market capitalization of $380.08 billion.
UnitedHealth Group IncorporatedStrong Q1 results, improved medical care ratio, raised FY2026 EPS guidance, and margin recovery focus.